Efficacy of losartan and carvedilol on central hemodynamics in hypertensives: A prospective, randomized, open, blinded end point, multicenter study

Hypertension Research

Volumn 37, Issue 1, 2014, Pages 50-56

  Kim, Eung Ju ^a   Song, Woo Hyuk ^a   Lee, Jae Ung ^b   Shin, Mi Seung ^c   Lee, Sahng ^d   Kim, Byeong Ok ^e   Hong, Kyeong Sun ^f   Han, Seong Woo ^f   Park, Chang Gyu ^a   Seo, Hong Seog ^a  

^a Korea University College of Medicine   (South Korea)

^b Hanyang University Guri Hospital   (South Korea)

^c Gachon University   (South Korea)

^d Eulji University   (South Korea)

^e Inje University College of Medicine   (South Korea)

^f Hallym University College of Medicine   (South Korea)

Author keywords

blood pressure; carvedilol; central hemodynamics; hypertension; losartan

Indexed keywords

C REACTIVE PROTEIN; CARVEDILOL; LOSARTAN; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

ABDOMINAL DISCOMFORT; ADULT; AORTA PRESSURE; ARTICLE; AUGMENTATION INDEX; BACKACHE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL PARAMETERS; CAROTID FEMORAL PULSE WAVE VELOCITY; CHRONIC SINUSITIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG OVERDOSE; DRUG SAFETY; DRUG WITHDRAWAL; FACE EDEMA; FEMALE; FOLLOW UP; HEART RATE; HEMATOMA; HEMODYNAMICS; HUMAN; HYPERTENSION; INTOXICATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; MYELITIS; NAUSEA; OPEN STUDY; ORAL BLEEDING; PROSPECTIVE STUDY; PULSE RATE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; TREATMENT DURATION; VARIANT ANGINA PECTORIS;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD PRESSURE; CARBAZOLES; DRUG THERAPY, COMBINATION; ENDPOINT DETERMINATION; FEMALE; HEART RATE; HEMODYNAMICS; HUMANS; HYPERTENSION; INFLAMMATION; LOSARTAN; MALE; MIDDLE AGED; PROPANOLAMINES; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS;

EID: 84891750249     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.112     Document Type: Article

References (40)

1. de Luca N, Asmar RG, London GM, O'Rourke MF, Safar ME. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens 2004; 22: 1623-1630. (Pubitemid 39037615)
2. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39: 10-15. (Pubitemid 34098081)
3. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, Witteman JC. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006; 113: 657-663.
4. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113: 1213-1225.
5. Holewijn S, den Heijer M, Stalenhoef AF, de Graaf J. Non-invasive measurements of atherosclerosis (NIMA): current evidence and future perspectives. Neth J Med 2010; 68: 388-399.
6. Wang KL, Cheng HM, Chuang SY, Spurgeon HA, Ting CT, Lakatta EG, Yin FC, Chou P, Chen CH. Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality? J Hypertens 2009; 27: 461-467.
7. Agabiti-Rosei E, Mancia G, O'Rourke MF, Roman MJ, Safar ME, Smulyan H, Wang JG, Wilkinson IB, Williams B, Vlachopoulos C. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 2007; 50: 154-160. (Pubitemid 46986036)
8. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241. (Pubitemid 34163575)
9. Laurent S, Cockcroft J, Van BL, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605. (Pubitemid 44627304)
10. Song HG, Kim EJ, Seo HS, Kim SH, Park CG, Han SW, Ryu KH. Relative contributions of different cardiovascular risk factors to significant arterial stiffness. Int J Cardiol 2010; 139: 263-268.
11. Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens 2004; 17: 118-123. (Pubitemid 38125127)
12. Hirata K, Vlachopoulos C, Adji A, O'Rourke MF. Benefits from angiotensin-converting enzyme inhibitor 'beyond blood pressure lowering': beyond blood pressure or beyond the brachial artery? J Hypertens 2005; 23: 551-556. (Pubitemid 40684713)
13. Dhakam Z, McEniery CM, Yasmin, Cockcroft JR, Brown MJ, Wilkinson IB. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens 2006; 19: 214-219. (Pubitemid 43350177)
14. Voelkel NF, Tuder RM. Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest 2000; 106: 733-738.
15. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995-1003. (Pubitemid 34286536)
16. Stafylas PC, Sarafidis PA. Carvedilol in hypertension treatment. Vasc Health Risk Manag 2008; 4: 23-30. (Pubitemid 351460844)
17. Pedersen ME, Cockcroft JR. The vasodilatory beta-blockers. Curr Hypertens Rep 2007; 9: 269-277. (Pubitemid 47377026)
18. Rajzer M, Klocek M, Kawecka-Jaszcz K. Effect of amlodipine, quinapril, and losartan on pulse wave velocity and plasma collagen markers in patients with mild-to-moderate arterial hypertension. Am J Hypertens 2003; 16: 439-444. (Pubitemid 36667797)
19. Davies J, Carr E, Band M, Morris A, Struthers A. Do losartan and atenolol have differential effects on BNP and central haemodynamic parameters? J Renin Angiotensin Aldosterone Syst 2005; 6: 151-153. (Pubitemid 43263354)
20. Hwang WM, Bae JH, Kim KY, Synn YC. Imacts of atherosclerotic coronary risk factors on atherosclerotic surrogates in patients with coronary artery disase. Korean Circ J 2005; 35: 131-139.
21. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, Kass DA. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 1997; 95: 1827-1836. (Pubitemid 27164400)
22. Chung JW, Lee YS, Kim JH, Seong MJ, Kim SY, Lee JB, Ryu JK, Choi JY, Kim KS, Chang SG, Lee GH, Kim SH. Reference values for the augmentation index and pulse pressure in apparently healthy korean subjects. Korean Circ J 2010; 40: 165-171.
23. Kang JH, Lee DI, Kim S, Kim SW, Im SI, Na JO, Choi CU, Lim HE, Kim JW, Kim EJ, Han SW, Rha SW, Seo HS, Oh DJ, Park CG. A comparison between central blood pressure values obtained by the Gaon system and the SphygmoCor system. Hypertens Res 2012; 35: 329-333.
24. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001; 38: 932-937. (Pubitemid 34258696)
25. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J 1993; 14: 160-167. (Pubitemid 23089501)
26. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 2000; 525: 263-270. (Pubitemid 30311951)
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
28. O'Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 2002; 15: 426-444. (Pubitemid 34478483)
29. Lim SY, Kim SW, Kim EJ, Kang JH, Kim SA, Kim YK, Na JO, Choi CU, Lim HE, Han SW, Rha SW, Park CG, Seo HS, Oh DJ. Telmisartan versus valsartan in patients with hypertension: effects on cardiovascular, metabolic, and inflammatory parameters. Korean Circ J 2011; 41: 583-589.
30. Boutouyrie P, Achouba A, Trunet P, Laurent S. Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study. Hypertension 2010; 55: 1314-1322.
31. Protogerou A, Blacher J, Stergiou GS, Achimastos A, Safar ME. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study. J Am Coll Cardiol 2009; 53: 445-451.
32. Reference Values for Arterial Stiffness' Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J 2010; 31: 2338-2350.
33. Kampus P, Serg M, Kals J, Zagura M, Muda P, Karu K, Zilmer M, Eha J. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness. Hypertension 2011; 57: 1122-1128.
34. Shimizu M, Kario K. Role of the augmentation index in hypertension. Ther Adv Cardiovasc Dis 2008; 2: 25-35. (Pubitemid 351583140)
35. Cecelja M, Jiang B, McNeill K, Kato B, Ritter J, Spector T, Chowienczyk P. Increased wave reflection rather than central arterial stiffness is the main determinant of raised pulse pressure in women and relates to mismatch in arterial dimensions: a twin study. J Am Coll Cardiol 2009; 54: 695-703.
36. Kelly RP, Millasseau SC, Ritter JM, Chowienczyk PJ. Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension 2001; 37: 1429-1433. (Pubitemid 34225387)
37. London GM, Asmar RG, O'Rourke MF, Safar ME. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 2004; 43: 92-99. (Pubitemid 38045921)
38. Williams B, Lacy PS. Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFEHeart Rate. J Am Coll Cardiol 2009; 54: 705-713.
39. Davies JI, Struthers AD. Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses. J Hypertens 2003; 21: 463-472. (Pubitemid 36418950)
40. Wilkinson IB, McEniery CM, Cockcroft JR. Pulse waveform analysis and arterial stiffness: realism can replace evangelism and scepticism. J Hypertens 2005; 23: 213. author reply 213-214.